{"schema_version":"secwatch.filing_event.v1","accession":"0000021076-24-000014","form_type":"8-K","ticker":"CLX","cik":"0000021076","company_name":"CLOROX CO /DE/","filed_at":"2024-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.461329+00:00","generated_at":"2026-06-03T04:52:48.946372+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Clorox Q3 net sales down 5% to $1.81B; adjusted EPS up 13% to $1.71","bullets":["Net sales fell 5% to $1.81B; organic sales up 2% despite cyberattack disruptions.","Diluted EPS loss of $0.41 vs loss of $1.71 YoY; adjusted EPS rose 13% to $1.71.","Gross margin expanded 40 bps to 42.2% on pricing and cost savings.","YTD operating cash flow $355M, down 51%; free cash flow $224M vs $584M.","Divested Argentina business on Mar 20; expects full distribution recovery by Q4 end."],"urls":{"canonical":"https://secwatch.observer/filing/0000021076-24-000014","json":"https://secwatch.observer/filing/0000021076-24-000014.json","markdown":"https://secwatch.observer/filing/0000021076-24-000014.md","text":"https://secwatch.observer/filing/0000021076-24-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/21076/000002107624000014/0000021076-24-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/21076/000002107624000014/clx-20240430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T04:52:48.946372+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5d6cefd129a9ee2333654f5da1351cc4a240594a","claim":"CLOROX CO /DE/ reported third quarter ended March 31, 2024 results: revenue $1.81 billion, EPS ($0.41) per diluted share.","evidence_excerpt":"20, 2024 divestiture of the company's Argentina business and all comparisons are with the third quarter of fiscal year 2023 unless otherwise stated. • Net sales decreased 5% to $1.81 billion compared to a 6% net sales increase in the year-ago quarter. The decrease was driven largely by lower volume from temporary distribution losses resulting from the widescale","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/21076/000002107624000014/0000021076-24-000014-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended March 31, 2024"},{"label":"Revenue","value":"$1.81 billion"},{"label":"EPS","value":"($0.41) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}